本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Zentalis Pharmaceuticals, LLC

3.51
-0.0800-2.23%
盤後3.520.0100+0.28%19:30 EDT
成交量:78.79萬
成交額:276.97萬
市值:3.32億
市盈率:-1.79
高:3.67
開:3.63
低:3.47
收:3.59
52周最高:6.95
52周最低:1.21
股本:9,467.19萬
流通股本:7,528.59萬
量比:0.87
換手率:1.05%
股息:- -
股息率:- -
每股收益(TTM):-1.9591
每股收益(LYR):-1.9100
淨資產收益率:-66.75%
總資產收益率:-33.15%
市淨率:2.31
市盈率(LYR):-1.84

資料載入中...

2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/25

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report